Accurate measurement of HMGB-1, neopterin and sIL-2R supports reliable assessment of immune activation across clinical and ...
Calidi Biotherapeutics, Inc. (NYSE American: CLDI) ('Calidi” or the 'Company”), a biotechnology company pioneering the development of targeted genetic medicines, presented new data at the American ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results